Lung Transplantation
- 14 February 2014
- journal article
- research article
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 111 (7), 107-16
- https://doi.org/10.3238/arztebl.2014.0107
Abstract
Lung transplantation is the final treatment option in the end stage of certain lung diseases, once all possible conservative treatments have been exhausted. Depending on the indication for which lung transplantation is performed, it can improve the patient's quality of life (e.g., in emphysema) and/ or prolong life expectancy (e.g., in cystic fibrosis, pulmonary fibrosis, and pulmonary arterial hypertension). The main selection criteria for transplant candidates, aside from the underlying pulmonary or cardiopulmonary disease, are age, degree of mobility, nutritional and muscular condition, and concurrent extrapulmonary disease. The pool of willing organ donors is shrinking, and every sixth candidate for lung transplantation now dies while on the waiting list. We reviewed pertinent articles (up to October 2013) retrieved by a selective search in Medline and other German and international databases, including those of the International Society for Heart and Lung Transplantation (ISHLT), Eurotransplant, the German Institute for Applied Quality Promotion and Research in Health-Care (Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen, AQUA-Institut), and the German Foundation for Organ Transplantation (Deutsche Stiftung Organtransplantation, DSO). The short- and long-term results have markedly improved in recent years: the 1-year survival rate has risen from 70.9% to 82.9%, and the 5-year survival rate from 46.9% to 59.6%. The 90-day mortality is 10.0%. The postoperative complications include acute (3.4%) and chronic (29.0%) transplant rejection, infections (38.0%), transplant failure (24.7%), airway complications (15.0%), malignant tumors (15.0%), cardiovascular events (10.9%), and other secondary extrapulmonary diseases (29.8%). Bilateral lung transplantation is superior to unilateral transplantation (5-year survival rate 57.3% versus 47.4%). Seamless integration of the various components of treatment will be essential for further improvements in outcome. In particular, the follow-up care of transplant recipients should always be provided in close cooperation with the transplant center.Keywords
This publication has 136 references indexed in Scilit:
- Comparative study of bronchial artery revascularization in lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2013
- A Comparative Analysis of Bronchial Stricture After Lung Transplantation in Recipients With and Without Early Acute RejectionThe Annals of Thoracic Surgery, 2013
- Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax, 2012
- Selecting lung transplant candidates: where do current guidelines fall short?Expert Review of Respiratory Medicine, 2012
- Reduction in Airway Complications After Lung Transplantation With Novel Anastomotic TechniqueThe Annals of Thoracic Surgery, 2011
- Respiratory and Skeletal Muscle Strength in Chronic Obstructive Pulmonary DiseaseJournal of Cardiopulmonary Rehabilitation and Prevention, 2011
- Bronchial blood supply after lung transplantation without bronchial artery revascularizationCurrent Opinion in Organ Transplantation, 2010
- Update on the diagnosis and treatment ofPneumocystispneumoniaTherapeutic Advances in Respiratory Disease, 2010
- Technology and Outcomes Assessment in Lung TransplantationProceedings of the American Thoracic Society, 2009
- Acute Rejection and Humoral Sensitization in Lung Transplant RecipientsProceedings of the American Thoracic Society, 2009